GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharma Foods International Co Ltd (TSE:2929) » Definitions » EBIT

Pharma Foods International Co (TSE:2929) EBIT : 円6,048 Mil (TTM As of Jan. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Pharma Foods International Co EBIT?

Pharma Foods International Co's earnings before interest and taxes (EBIT) for the three months ended in Jan. 2024 was 円950 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jan. 2024 was 円6,048 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Pharma Foods International Co's annualized ROC % for the quarter that ended in Jan. 2024 was 6.71%. Pharma Foods International Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was 47.78%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Pharma Foods International Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was 22.00%.


Pharma Foods International Co EBIT Historical Data

The historical data trend for Pharma Foods International Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Foods International Co EBIT Chart

Pharma Foods International Co Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 675.94 856.00 5,777.00 1,449.00 3,590.00

Pharma Foods International Co Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,273.00 2,510.00 1,969.00 619.00 950.00

Competitive Comparison of Pharma Foods International Co's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Pharma Foods International Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Foods International Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharma Foods International Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Pharma Foods International Co's EV-to-EBIT falls into.



Pharma Foods International Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円6,048 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharma Foods International Co  (TSE:2929) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Pharma Foods International Co's annualized ROC % for the quarter that ended in Jan. 2024 is calculated as:

ROC % (Q: Jan. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Oct. 2023 ) + Invested Capital (Q: Jan. 2024 ))/ count )
=3736 * ( 1 - 48.67% )/( (28621 + 28523)/ 2 )
=1917.6888/28572
=6.71 %

where

Note: The Operating Income data used here is four times the quarterly (Jan. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Pharma Foods International Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jan. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Oct. 2023  Q: Jan. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=3800/( ( (4568 + max(3553, 0)) + (4555 + max(3229, 0)) )/ 2 )
=3800/( ( 8121 + 7784 )/ 2 )
=3800/7952.5
=47.78 %

where Working Capital is:

Working Capital(Q: Oct. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3851 + 5720 + 1279) - (6418 + 0 + 879)
=3553

Working Capital(Q: Jan. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3609 + 5872 + 1201) - (6628 + 0 + 825)
=3229

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jan. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Pharma Foods International Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jan. 2024 )
=6048/27496.276
=22.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharma Foods International Co EBIT Related Terms

Thank you for viewing the detailed overview of Pharma Foods International Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Foods International Co (TSE:2929) Business Description

Traded in Other Exchanges
N/A
Address
1-49 Ohara Kyoto imperial tomb Saikyo-ku, Kyoto, JPN, 615-8245
Pharma Foods International Co Ltd is engaged in the development and sales of functional food materials.

Pharma Foods International Co (TSE:2929) Headlines

No Headlines